ArticleJournal of cachexia, sarcopenia and muscle2025
Integrating Body Composition and Nutritional Indices: A Novel Prognostic Tool for Survival in Pancreatic Cancer.
Article in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Integrating Leg-Press Strength and Nutritional Status Improves 16-Year Mortality Risk Stratification in General Older Adults.Journal of cachexia, sarcopenia and muscle · 2026Article
- Leveraging Multiomic Signatures to Predict Body Composition.Advances in nutrition (Bethesda, Md.) · 2026Review
- Global Research Trends in Nutritional Management of Gastrointestinal Cancers: a 2004-2024 Bibliometric and knowledge-mapping Analysis.Journal of gastrointestinal cancer · 2026Review
- Dietitian-led individualized pancreatic enzyme replacement therapy is associated with favorable nutritional and immune-inflammatory profiles in pancreatic cancer: a retrospective cohort study.Frontiers in nutrition · 2026Article
- Integrating Body Composition and Nutritional Indices: A Novel Prognostic Tool for Survival in Pancreatic Cancer.Journal of cachexia, sarcopenia and muscle · 2025Article
- Significance of the geriatric nutritional risk index and body composition as prognostic indicators in gastric cancer patients.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSarcopenia and malnutrition have been independently associated with a poorer prognosis in pancreatic ductal adenocarcinoma (PDAC), but their combined association with patient outcomes is not fully understood. This study aimed to systematically evaluate the synergistic effects of body composition parameters and nutritional index as prognostic indicators in patients with PDAC.
methodsA total of 596 patients with PDAC who underwent surgical resection from two centres were initially enrolled in this retrospective study. Body composition parameters, including the skeletal muscle index (SMI), subcutaneous adipose tissue index (SATI), visceral adipose tissue index (VATI) and skeletal muscle density (SMD), were assessed using a single cross-sectional image at the L3 level from preoperative computed tomography scans. The prognostic nutritional index (PNI) was used to assess nutritional status. The combined indices were defined as body composition parameters multiplied by PNI.
resultsA total of 463 patients were finally included in the analysis, with 339 in the training cohort and 124 in the validation cohort. The median (interquartile) age was 66 (60-72) years, and 274 (59.2%) were male. The median values of SMI, SATI, VATI, SMD, as well as the combined indices of these parameters with PNI, varied significantly by sex in the training cohort. Patients were categorized into sex-specific quartiles (Q1 to Q4) based on SMI × PNI levels. Both overall survival (OS) and disease-free survival (DFS) exhibited significant differences across these quartiles (p < 0.001). Though all body composition parameters and their combinations with PNI were independent predictors of OS in multivariate analysis, the combination of SMI × PNI demonstrated superior prognostic performance compared to other indices (c-statistics: 0.767, AICc: 1648.8). These results remained consistent across stratified analysis. The external validation cohort confirmed that SMI × PNI exhibited enhanced predictive and discriminative power compared with other indices.
conclusionsSMI × PNI represents a robust and accessible prognostic tool for assessing survival in patients with PDAC. Further prospective studies are needed to validate its effectiveness across diverse populations and clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.